- Recap allowed Global Med to separate itself from a troublesome investor and eliminate close to $1MM in annual interest payments.
- Strengthened Global Med’s balance sheet.
- Investors Crestview Capital and Fusion Capital were strong GLOB partners leading up to the 2010 sale to Haemonetics.
Overview
Leading provider of health care information management software raised $13.4MM from institutional investors in a PIPE transaction.
Simultaneously, proceeds were used to redeem or buy back GLOB securities held by Hong Kong-based Global Med Int’l Limited.
Significance
Catapult’s role
- Reached out to a wide variety of potential investors including late stage VC, private equity and hedge funds.
- Put together a syndicate of interested investors and spearheaded pricing negotiations.
- Structured a very complex series of transactions involving common stock, convertible preferred stock and warrants.
“Catapult was creative, diligent and persistent in getting the job done.”
